Partner
Dr. Antje Brambrink is qualified and admitted as an attorney at law in Germany. She advises and represents clients in complex patent disputes on all IP-related matters, often at the interface of antitrust and regulatory laws. Her expertise covers various fields of technology with a focus on pharmaceuticals, biotechnology, med-tech, as well as renewable energies and high-tech. Our clients appreciate Antje’s deep understanding of the life sciences sector based on her dual qualification as a licensed dentist.
As a patent litigator, Antje represents clients in infringement, preliminary injunction and inspection proceedings before German district and appeal courts as well as in nullity and compulsory license proceedings at the German Federal Patent Court and the Federal Supreme Court.
In addition to her work as a litigator, Antje advises clients strategically on all issues relating to intellectual property rights (patents, utility models, supplementary protection certificates), such as contracts for the licensing and transfer of rights also in connection with international transactions or the newly established Unified Patent Court (UPC). She has extensive experience in the European coordination of multinational patent disputes.
Prior to joining Finnegan, Antje practiced patent litigation for several years in the patent litigation teams of two international law firms seated in Germany. Antje’s medical and scientific background is of great benefit in advising clients from the life sciences sector. Renowned pharmaceutical, biotechnology and medical devices companies regularly seek her advice. She also advises in the field of renewable energies and in the enforcement of standard-essential patents (SEPs).
Antje frequently comments on recent case law in German IP journals. Intellectual Asset Management’s (IAM) Strategy 300 named Antje as a Global Leader for 2023, and Managing Intellectual Property (MIP) recognized her as notable practitioner.
Coordinated a European patent dispute on pharmaceuticals*
Represented a company in compulsory license proceedings*
BPatG
German Civil Patent Courts
EPO
Represented a pharmaceutical company before German Civil Patent Courts*
German Civil Patent Courts
Represented a pharmaceutical originator before German Civil Patent Courts*
German Civil Patent Courts
Represented a renewable energy company in infringement and nullity proceedings*
German Civil Patent Courts
BPatG
BGH
European IP Blog
UPC Central Division Revokes Patent Covering Covid-19 Treatment Remdesivir UPC Central Division Revokes Patent Covering Covid-19 Treatment Remdesivir
8 June 2026
Webinar
Implementation of Long-Arm Jurisdiction by the UPC Court and German National Courts: Strategic Considerations and Practical Implications Implementation of Long-Arm Jurisdiction by the UPC Court and German National Courts: Strategic Considerations and Practical Implications
May 12, 2026
Webinar
Panel Discussion
Global Patent Strategies & Litigation: An Exclusive Off-the-Record Conversation with Experienced In-House Leaders Global Patent Strategies & Litigation: An Exclusive Off-the-Record Conversation with Experienced In-House Leaders
May 5, 2026
London
Seminar
The Doctrine of Equivalents at the UPC The Doctrine of Equivalents at the UPC
April 16, 2026
Munich
Conference
2026 FCBA Global Series Spring Session 2026 FCBA Global Series Spring Session
April 8, 2026
Washington, DC
Articles
The UPC - Only Three Years Old and Already Leading The UPC - Only Three Years Old and Already Leading
March 18, 2026
Intellectual Asset Management (IAM)Award/Ranking
Finnegan Earns Top Rankings in 2026 IAM Patent 1000 Guide; Nearly 60 Attorneys Ranked Finnegan Earns Top Rankings in 2026 IAM Patent 1000 Guide; Nearly 60 Attorneys Ranked
May 28, 2026
Intellectual Asset Management (IAM)Award/Ranking
Finnegan Partner Antje Brambrink Shortlisted for Women in Business Law EMEA Award Finnegan Partner Antje Brambrink Shortlisted for Women in Business Law EMEA Award
May 13, 2026
Women in Business LawAward/Ranking
Seven Finnegan Partners Named to IAM Strategy 300 Global Leaders 2026 Seven Finnegan Partners Named to IAM Strategy 300 Global Leaders 2026
November 19, 2025
Intellectual Asset Management (IAM)Award/Ranking
Seven Finnegan Attorneys Named to the 2025 IAM Strategy 300 List Seven Finnegan Attorneys Named to the 2025 IAM Strategy 300 List
August 13, 2025
Intellectual Asset Management (IAM)Award/Ranking
Best Lawyers in Germany Recognizes Four Finnegan Partners in Recent Rankings Best Lawyers in Germany Recognizes Four Finnegan Partners in Recent Rankings
June 12, 2025
Best LawyersAward/Ranking
50 Finnegan Attorneys Ranked in the 2025 IAM Patent 1000 50 Finnegan Attorneys Ranked in the 2025 IAM Patent 1000
June 2, 2025
Intellectual Asset Management (IAM)Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.